$300M Series D funding secured & Dr. Omar Ishrak appointed Biofourmis Chairman Learn More
ARH will leverage Biofourmis’ solution in a prestigious Rural Home Hospital program launched by joint venture of Brigham and Women’s Hospital and the Harvard T.H.
Health system to utilize AI-powered Biovitals® Hospital@Home™ platform to deliver inpatient-level care within patients’ homes with plans to offer additional remote patient monitoring for post-acute
Biofourmis Care, a comprehensive care management platform including virtual multidisciplinary care teams, to be evaluated against in-person care among underserved patients with chronic cardiovascular conditions
$300M Series D to fund continued growth of Biofourmis’ innovative virtual solutions Dr. Omar Ishrak Appointed Biofourmis Chairman BOSTON, April 26, 2022 – Biofourmis, a
Leader in virtual care and remote patient management solutions will enable integrated health system serving three states to participate in rural hospital research study and
Oncology patients treated with Kite’s YESCARTA® will be monitored remotely to identify signs of potential adverse side effects; clinicians may intervene based on clinical data,
First of its kind service combines a specialized, multidisciplinary clinical care team with an AI-enabled care management platform for automated medication management, earlier interventions and
Leading U.S. academic medical center to deliver hospital-level care in patients’ homes and continuous monitoring of recently discharged patients using the Biofourmis platform BOSTON –
Comprehensive, turnkey platform that delivers inpatient-level care at home earns recognition for “Digital/Mobile Health Solution” and “Best in Show: Cost Saving” BOSTON, December 13, 2021
Care New England to continuously monitor patients across a variety of conditions with Biofourmis’ proven technology, offering predictive insight to Integra clinicians PROVIDENCE, R.I., October
11th Annual Award Judged by Pharma and Life Sciences Leaders Recognizes Disruptive Innovations to Advance Clinical Research BOSTON, October 11, 2021 – Biofourmis, a Boston-based
BiovitalsHF® Approved for Expedited FDA Review Process as a First-in-Class DTx for Heart Failure that Augments Traditional Guideline-Directed Medical Therapy BOSTON, July 29, 2021 –
Sheeza Khawar Hussain to Accelerate Market Growth for Biofourmis’ Care-at-Home Technology Solutions, including Hospital at Home BOSTON, June 23, 2021 – Biofourmis, a Boston-based
Former Amazon Medical Officer and Massachusetts General Hospital Cardiologist to Lead Product Management, Data Science and Clinical Affairs for Fast-Growing Tech-Enabled Care Delivery Company BOSTON, May
– To immediately expand hospital capacity during the COVID-19 public health emergency, CMS has announced the Acute Hospital at Home program waiver that provides full
Funding to advance “home hospital” initiatives with health systems and “beyond the pill” digital medicine partnerships with pharmaceutical companies BOSTON, Sept. 3, 2020 /PRNewswire/ — Biofourmis, a fast-growing
– COVID-19 patients in Singapore are being monitored using Biofourmis’ cutting-edge wearable and artificial intelligence technology to accelerate disease surveillance and interventions – Biofourmis staff
– Chugai and Biofourmis are partnering to develop a digital solution leveraging Biofourmis’ Biovitals® platform for pain management in patients with endometriosis – A non-interventional
Finance leader Matt Borowiecki brings deep M&A and fundraising experience to his new role BOSTON, May 26, 2020 /PRNewswire/ — Biofourmis, a fast-growing global leader in digital
Acquisition of Gaido Health from Takeda Digital Ventures builds Biofourmis’ digital medicine portfolio in oncology, while improving the care experience for cancer patients and providers
– First-of-its-kind program administered by The University of Hong Kong has international implications and applications as COVID-19 continues to spread – Clinicians to leverage Biofourmis’
Biofourmis’ artificial intelligence-powered RhythmAnalytics® to provide clinical decision support that IDs cardiac arrhythmias and other issues requiring intervention BOSTON, Jan. 30, 2020 /PRNewswire/ — Biofourmis, a fast-growing global
COO Jaydev Thakkar brings deep clinical trial and digital medicine experience; CTO Milan Shah is a former Microsoft developer who has grown and sold four
– Novartis to leverage Biofourmis’ lead digital medicine product to remotely manage patients with heart failure across Asia – Alliance combines Novartis access solutions for
Acquisition of Biovotion establishes Biovitals® as the most comprehensive predictive digital medicine solution for healthcare providers, payers and pharmaceutical companies by combining best-in-class medical data
Milestone approval establishes AI-powered solution as the foundation for future disease-specific predictive management tools from Biofourmis BOSTON, Oct. 3, 2019 /PRNewswire/ — Biofourmis, a fast-growing global leader
CEO Kuldeep Singh Rajput will also speak at CB Insights’ Future of Health conference about what’s ahead for digital medicine NEW YORK, Oct. 2, 2019 /PRNewswire/
Biofourmis’ innovative technology to measure patient-centric endpoints to inform future drug development BOSTON, July 16, 2019 /PRNewswire/ — Biofourmis, a fast-growing global leader in digital medicine, has
Funding to grow clinically validated solution that combines AI, drug therapies, wearable sensors and smartphone app to deliver better patient outcomes BOSTON, May 21, 2019 /PRNewswire/
